Hub-and-Spoke Model Effectively Expands Naloxone Access in Community Pharmacies ...
Sugar, We’re Going Down: Navigating Glycemic Control in the Era of PI3K/AKT Inhibition for Breast Cancer 1.0 Credit / Breast Cancer, Endocrinology, Diabetes & Metabolism, Oncology, Patient Safety, ...
Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes. Interest in peptides is growing among both patients ...
This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations. The FDA approved Brytly (apraclonidine ophthalmic solution 0.125%) Friday as a ...
Throughout October, key recognition dates highlight the profession’s diverse workforce, including National Student ...
Lara Zakaria, PharmD, MS, CNS, FMCP, discusses her perspectives regarding the emergence of wearable technology among community pharmacy patients.
During American Pharmacists Month, pharmacy teams reflect on their roles and explore ways to enhance patient care. True leadership in pharmacy requires complete dedication rather than tentative ...
A gap between perceived and actual risk, messaging that has not reached women, and long drive times to a prescriber all limit PrEP uptake. The faculty examine what sustains PrEP deserts and how to ...
At eligible safety-net organizations, the 340B Drug Pricing Program may also support access. However, discounted acquisition costs do not establish a patient’s final charge. Pharmacists should confirm ...
Melissa McGivney, PharmD, FAPhA, FCCP, helps celebrate American Pharmacists Month and the innovation driving the profession forward amongst US communities. Melissa McGivney, PharmD, FAPhA, FCCP, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results